A recent study also demonstrated that high ezrin expression could promote processes involved in tumorigenesis including cell proliferation, colony formation and migration, which may preliminarily explain the reason why ezrin predicts poor prognosis in breast cancer [15,27], pancreatic cancer [11,12,28], ovarian cancers [10] and osteosarcomas [3]. This evidence concerns the gene EZR and ovarian cancer.